How to Price and to Reimburse Publicly Funded Medicines in Latin America? Lessons Learned from Europe

被引：1

作者：

Leopold, Christine ^{[1
]}

Poblete, Sergio ^{[2
]}

Vogler, Sabine ^{[3
,4
,5
]}

机构：

[1] Triangulate Hlth Ltd, Doncaster, England

[2] Minist Hlth Santiago, Dept Hlth Econ, Santiago, Chile

[3] Austrian Natl Publ Hlth Inst, Pharmacoecon Dept, Vienna, Austria

[4] WHO Collaborating Ctr Pharmaceut Pricing & Reimbu, Pharmacoecon Dept, Vienna, Austria

[5] Tech Univ Berlin, Dept Hlth Care Management, Berlin, Germany

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2023年 / 51卷

关键词：

Pricing; Reimbursement; Health Technology Assessment; Latin America; Europe; HEALTH TECHNOLOGY-ASSESSMENT; DECISION-MAKING;

D O I：

10.1017/jme.2023.114

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

This paper reviews the main pricing policies in Latin American countries, discussing their shortcomings. It also gives an overview of the most common pricing and reimbursement policies in Europe and describes in detail three well-established approaches - international price referencing, value-based pricing, including setting up of health technology assessment, and generic and biosimilar policies - building on country examples.

引用

页码：76 / 91

页数：16

共 80 条

[1] Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil
Abou Salha, Leila
Reis, Flavia Costa
Goncalves, Roberta Moreira
da Silva Lima, Jordao Horacio
Abou Salha, Nadia
Pinto, Roney Pereira
de Menezes, Jose Elmo
Oliveira, Eduardo Perez
Ferreira, Pedro Lopes
Barbosa, Maria Alves
[J]. INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2022, 21 (01)
[2] Acosta A., 2019, Revista De Direito Sanitario
[3] Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies
Acosta, Angela
Ciapponi, Agustin
Aaserud, Morten
Vietto, Valeria
Austvoll-Dahlgren, Astrid
Koesters, Jan Peter
Vacca, Claudia
Machado, Manuel
Hazbeydy Diaz Ayala, Diana
Oxman, Andrew D.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
[4] FIRST EVALUATION OF COLOMBIAN'S EXTERNAL REFERENCE PRICING SYSTEM
Andia, T.
Gaviria, A.
Gomez, C.
Jaramillo, L. F.
Marquez, S.
Rodriguez, I
Vaca, C.
[J]. VALUE IN HEALTH, 2014, 17 (03) : A15 - A15
[5] Andia T., 2018, El 'Efecto Portafolio' de La Regulacion de Precios de Medicamentos: La Respuesta de La Industria Farmaceutica a La Regulacion de Precios de Medicamentos En Colombia
[6] Is the judicialization of health care bad for equity? A scoping review
Andia, Tatiana S.
Lamprea, Everaldo
[J]. INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2019, 18 (1)
[7] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
Angelis, Aris
Lange, Ansgar
Kanavos, Panos
[J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (01) : 123 - 152
[8] [Anonymous], 2020, Decreto supremo N 4452
[9] [Anonymous], 2020, Proyecto de Ley 5311
[10] [Anonymous], 2020, WHO GUIDELINE COUNTR

← 1 2 3 4 5 6 7 8 →